Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.
作者信息
Nakatani Shinya, Ishimura Eiji, Machiba Yuri, Nakatani Ayumi, Fujimoto Kenta, Uedono Hideki, Okute Yujiro, Tsuda Akihiro, Mori Katsuhito, Emoto Masanori, Inaba Masaaki
机构信息
Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
出版信息
Nephrology (Carlton). 2018 Aug;23(8):798-799. doi: 10.1111/nep.13196.
PMID:30920106
Abstract
摘要
Zotero 插件